Prioritising patients in negotiations over drug pricing

BMJ

14 April 2023 - Overpaying for medicines diverts funds away from other treatments and services.

For over six decades, an agreement has been brokered every five years or so between the UK government and the drug industry, shaping the pricing and reimbursement landscape for medicines in the UK.

Read BMJ article

Michael Wonder

Posted by:

Michael Wonder